107 related articles for article (PubMed ID: 7577195)
1. Synthesis, analysis and toxicity of three compounds formed during the synthesis of iodixanol.
Priebe H; Dugstad H; Heglund IF; Sande R; Tønseth CP
Acta Chem Scand (Cph); 1995 Oct; 49(10):737-43. PubMed ID: 7577195
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of iodixanol.
Priebe H; Dugstad H; Gacek M; Hagen E; Homestad OM; Larsen A; Sjogren CE; Thomassen T
Acta Radiol Suppl; 1995; 399():21-31. PubMed ID: 8610518
[TBL] [Abstract][Full Text] [Related]
3. Stability of the X-ray contrast agent iodixanol=3,3',5,5'-tetrakis(2,3-dihydroxypropylcarbamoyl)- 2,2',4,4',6, 6'-hexaiodo-N,N'-(2-hydroxypropane-1,3-diyl)-diacetanili de towards acid, base, oxygen, heat and light.
Priebe H; Aukrust A; Bjørsvik HR; Tønseth CP; Wiggen UN
J Clin Pharm Ther; 1999 Jun; 24(3):227-35. PubMed ID: 10438183
[TBL] [Abstract][Full Text] [Related]
4. [Mutagenicity studies of iodixanol, a new non-ionic isotonic contrast medium].
Igarashi M; Nakayama S; Jones E; Shimada H
J Toxicol Sci; 1995 Oct; 20 Suppl 1():125-31. PubMed ID: 7490784
[TBL] [Abstract][Full Text] [Related]
5. X-ray contrast agents. I. Synthesis of some derivatives of 5-amino-2,4,6-triiodoisophthalamide.
Haavaldsen J; Nordal V; Kelly M
Acta Pharm Suec; 1983; 20(3):219-32. PubMed ID: 6637517
[No Abstract] [Full Text] [Related]
6. Synthesis, analysis and toxicity of some compounds which may be formed during the synthesis of iopentol.
Berg A; Fagervoll R; Aulie Michelet A; Dugstad H
Acta Radiol Suppl; 1987; 370():27-31. PubMed ID: 2980307
[TBL] [Abstract][Full Text] [Related]
7. Bioanalytical methods for iodixanol and their application to studies on metabolism and protein binding.
Jacobsen PB; Blindheim L; Skotland T
Acta Radiol Suppl; 1995; 399():61-6. PubMed ID: 8610531
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of an HPLC-UV method for iodixanol quantification in human plasma.
Chitnis SD; Akhlaghi F
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):133-7. PubMed ID: 18502708
[TBL] [Abstract][Full Text] [Related]
9. Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and computed tomography in rats.
Wang YC; Tang A; Chang D; Zhang SJ; Ju S
Invest Radiol; 2014 Nov; 49(11):699-706. PubMed ID: 24879299
[TBL] [Abstract][Full Text] [Related]
10. Effects of non-ionic monomeric and dimeric iodinated contrast media on renal and systemic haemodynamics in rats.
Idée JM; Lancelot E; Berthommier C; Couturier-Goulas V; Vazin V; Corot C
Fundam Clin Pharmacol; 2000; 14(1):11-8. PubMed ID: 10681069
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
[TBL] [Abstract][Full Text] [Related]
12. Temperature effects on packed-capillary liquid chromatography of the X-ray contrast agent iodixanol.
Molander P; Theodorsen M; Lundanes E; Soerenssen DM; Greibrokk T
J Chromatogr Sci; 2000 Apr; 38(4):157-61. PubMed ID: 10766482
[TBL] [Abstract][Full Text] [Related]
13. Neural tolerability of iodixanol in mice and dogs after single and repeated intracisternal administration.
Larsen LE; Heglund IF; Fabian R; Walday P; Blazak WF
Acta Radiol Suppl; 1995; 399():238-43. PubMed ID: 8610522
[TBL] [Abstract][Full Text] [Related]
14. Simple isocratic high-performance liquid chromatographic method for measurement of iodixanol in human plasma.
Nomura H; Teshima E; Hakusui H
J Chromatogr; 1991 Dec; 572(1-2):333-8. PubMed ID: 1818070
[TBL] [Abstract][Full Text] [Related]
15. [Toxicity of iodixanol, a new nonionic iso-osmolar contrast medium, to rats by repeated intravenous administration for 4 weeks with a 4-week recovery period].
Ohno H; Crome SJ; Furuhama K; Nomura M; Onodera T
J Toxicol Sci; 1995 Oct; 20 Suppl 1():67-85. PubMed ID: 7490790
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography.
Sahani DV; Soulez G; Chen KM; Lepanto L; Xu JR; Nelson RC; Grazioli L; Vanzulli A; Heiken JP;
Invest Radiol; 2007 Dec; 42(12):856-61. PubMed ID: 18007158
[TBL] [Abstract][Full Text] [Related]
17. On-line dialysis and quantitative high-performance liquid chromatography analysis of iodixanol in human, rat and monkey plasma.
Jacobsen PB
J Chromatogr B Biomed Sci Appl; 2000 Nov; 749(1):135-42. PubMed ID: 11129073
[TBL] [Abstract][Full Text] [Related]
18. Iodixanol induces apoptotic and antiproliferative effects but no necrotic cell death in renal proximal tubular cells in vitro.
Heinrich MC; Scheer M; Heckmann M; Kuefner MA; Uder M
Rofo; 2009 Apr; 181(4):349-54. PubMed ID: 19291604
[TBL] [Abstract][Full Text] [Related]
19. [Toxicity of iodixanol, a new nonionic iso-osmolar contrast medium, to cynomolgus monkeys by repeated intravenous administration for 4 weeks with a 4-week recovery period].
Ohno H; Crome SJ; Genda Y; Furuhama K; Nomura M; Onodera T
J Toxicol Sci; 1995 Oct; 20 Suppl 1():87-105. PubMed ID: 7490791
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
